跳到主要內容

Rubin Gary D 的 Form 4 申報

bioAffinity Technologies, Inc.(BIAF),2022/10/21 申報

申報編號
0001493152-22-029376
申報時間
2022/10/21 18:50 ET
交易日
2022/7/20-9/6
申報延遲
93 天遲報
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 8 筆非衍生性交易、13 筆衍生性交易。交易後 93 天才申報,超過 2 個營業日的期限。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Rubin Gary DCIK 0001947569董事、持股 10% 以上大股東
Harvey Sandler Revocable TrustCIK 0001323253持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/9/6Common StockC轉換取得+15,876$4.20F4+$66,679.251,590直接
2022/9/6Common StockC轉換取得+266,850$4.20F5+$1,120,7701,082,866間接
2022/9/6Common StockC轉換取得+38,287$4.20F6+$160,805.41,121,153間接
2022/9/6Common StockC轉換取得+93,821$4.20F7+$394,048.21,214,974間接
2022/9/6Common StockC轉換取得+63,958$4.20F8+$268,623.61,278,932間接
2022/9/6Common StockC轉換取得+58,577$4.20F9+$246,023.41,337,509間接
2022/9/6Common StockC轉換取得+230,309$5.17F10+$1,190,697.531,567,818間接
2022/8/31Common StockP買進取得+16,326–F11–1,584,144間接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2022/9/6Common StockC轉換處分−15,876$0.00–0直接
2022/9/6Common StockC轉換處分−266,850$0.00–0間接
2022/9/6Common StockC轉換處分−38,287$0.00–0間接
2022/9/6Common StockC轉換處分−93,821$0.00–0間接
2022/9/6Common StockC轉換處分−63,958$0.00–0間接
2022/9/6Common StockC轉換處分−58,577$0.00–0間接
2022/9/6Common StockC轉換處分−230,309$0.00$00間接
2022/8/31Common StockP買進取得+16,326–F11–16,326間接
2022/8/31Common StockP買進取得+16,326–F11–16,326間接
2022/9/6Common StockA公司授予取得+12,241–F12–12,241直接
2022/9/6Common StockP買進取得+408,125–F13–408,125間接
2022/7/20Common StockA公司授予取得+4,896–F14–4,896直接
2022/7/20Common StockP買進取得+163,248–F15–163,248間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F4

In connection with the closing of the Issuer's IPO (the "IPO Closing") on September 6, 2022, the $66,682.86 of outstanding principal and accrued but unpaid interest of this secured convertible promissory note (a "Note"), dated December 21, 2018, automatically converted into 15,876 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).

表 I 有 1 筆交易的價格引用這則附註。

F5

In connection with the IPO Closing on September 6, 2022, the $1,120,773.84 of outstanding principal and accrued but unpaid interest of this Note, dated December 21, 2018, automatically converted into 266,850 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).

表 I 有 1 筆交易的價格引用這則附註。

F6

In connection with the IPO Closing on September 6, 2022, the $160,808.22 of outstanding principal and accrued but unpaid interest of this Note, dated February 7, 2019, automatically converted into 38,287 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).

表 I 有 1 筆交易的價格引用這則附註。

F7

In connection with the IPO Closing on September 6, 2022, the $394,048 of outstanding principal and accrued but unpaid interest of this Note, dated April 18, 2019, automatically converted into 93,821 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).

表 I 有 1 筆交易的價格引用這則附註。

F8

In connection with the IPO Closing on September 6, 2022, the $268,626.30 of outstanding principal and accrued but unpaid interest of this Note, dated July 26, 2019, automatically converted into 63,958 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).

表 I 有 1 筆交易的價格引用這則附註。

F9

In connection with the IPO Closing on September 6, 2022, the $246,027.40 of outstanding principal and accrued but unpaid interest of this Note, dated October 22, 2019, automatically converted into 58,577 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis).

表 I 有 1 筆交易的價格引用這則附註。

F10

In connection with the IPO Closing on September 6, 2022, the 1,612,163 shares of Series A Preferred Stock owned by the Trust automatically converted at the then-effective 1-for-7 conversion rate into 230,309 fully paid and nonassessable shares of Common Stock. The Series A Preferred Stock had no expiration date.

表 I 有 1 筆交易的價格引用這則附註。

F11

The reported securities are included within 16,326 Units purchased by the Trust for $6.125 per Unit in the Issuer's IPO. Each Unit consists of one share of Common Stock, one tradeable warrant to purchase one share of Common Stock at an exercise price of $7.35 per share, and one five-year non-tradeable warrant to purchase one share of Common Stock at an exercise price of $7.656 per share.

表 I 有 1 筆、表 II 有 2 筆交易的價格引用這則附註。

F12

Represents a right to purchase 12,241 shares of Common Stock underlying a warrant that became initially exercisable in connection with the IPO Closing on September 6, 2022 at an exercise price equal to the IPO price of $6.125 per share. The warrant was issued to Mr. Rubin on August 25, 2021 as consideration for his agreement to enter into an amendment to that certain Secured Convertible Note Purchase Agreement, dated December 21, 2018, as amended (the "Note Purchase Agreement") to extend the maturity date of the Note issued to him under the Note Purchase Agreement from December 31, 2021 to May 31, 2022.

表 II 有 1 筆交易的價格引用這則附註。

F13

Represents a right to purchase an aggregate of 408,125 shares of Common Stock underlying five warrants that became initially exercisable in connection with the IPO Closing on September 6, 2022 at an exercise price equal to the IPO price of $6.125 per share. The warrants were issued to the Trust on August 25, 2021 as consideration for the Trust's agreement to enter into an amendment to the Note Purchase Agreement to extend the maturity date of the Notes issued to the Trust under the Note Purchase Agreement from December 31, 2021 to May 31, 2022.

表 II 有 1 筆交易的價格引用這則附註。

F14

Represents a right to purchase 4,896 shares of Common Stock underlying a warrant at an exercise price of $5.25 per share. The warrant was issued to Mr. Rubin on July 20, 2022 as consideration for his agreement to enter into an amendment to the Note Purchase Agreement to extend the maturity date of the Note issued to him under the Note Purchase Agreement from August 31, 2022 to October 31, 2022.

表 II 有 1 筆交易的價格引用這則附註。

F15

Represents a right to purchase an aggregate of 163,248 shares of Common Stock underlying five warrants at an exercise price of $5.25 per share. The warrants were issued to the Trust on July 20, 2022 as consideration for the Trust's agreement to enter into an amendment to the Note Purchase Agreement to extend the maturity date of the Notes issued to the Trust under the Note Purchase Agreement from August 31, 2022 to October 31, 2022.

表 II 有 1 筆交易的價格引用這則附註。

備註

Exhibit List - Exhibit 24.1: Power of Attorney (Gary D. Rubin) Exhibit 24.2: Power of Attorney (Harvey Sandler Revocable Trust)

看 SEC EDGAR 上的完整原文 (在新分頁開啟)